English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduFor many students, summer break represents an opportunity for relaxation and carefree vacations. But for the medical students taking part in the USC/CHLA Summer Oncology Research Fellowship (SORF) Program, summer means something more
Tag: oncology research
Dr. Daniel Geynisman Named New Editor-in-Chief for JNCCN—Journal of the National Comprehensive Cancer Network
Daniel M. Geynisman, MD, is being announced the new Editor-in-Chief for JNCCN—Journal of the National Comprehensive Cancer Network. Dr. Geynisman, Chief of the Division of Genitourinary Medical Oncology at Fox Chase Cancer Center, has a long history of working with NCCN in a variety of roles.
AACR: MD Anderson’s Scott Kopetz and Elizabeth Travis honored with 2024 Scientific Achievement Awards
Two researchers from The University of Texas MD Anderson Cancer Center will be honored with Scientific Achievement Awards at the American Association for Cancer Research (AACR) Annual Meeting 2024 for accomplishments in clinical and translational research as well as outstanding leadership in oncology.
USC/CHLA Summer Oncology Research Fellowship Supports Medical Students Aspiring to Becoming Physician-Scientists
Incorporating bench research into patient care at the bedside has been the guiding rationale behind the Summer Oncology Research Fellowship (SORF) program at Children’s Hospital Los Angeles and USC for over 45 years and is why the National Institutes of Health sponsors the program.
National Comprehensive Cancer Network Updates Annual Conference with New In-Person Venue, Hybrid Format, Expert-Led Sessions, Highlighted Research Perspectives, and Small-Group Conversations
NCCN 2023 Annual Conference featuring more than a thousand worldwide oncology professionals will present new research findings, latest NCCN Guidelines updates, and best practices for achieving quality cancer care delivery, in Orlando and online March 31—April 2, 2023. Visit NCCN.org/conference for more.
Multiplication on, multiplication off: Targeting an enzymatic switch to develop oncology drugs
Interdisciplinary research highlighted lipid-protein interaction as a new avenue for oncology drug development, demonstrating its functionality by designing small molecule-based inhibitors to target acute myeloid leukemia.
NCCN Explores Adoption of Biosimilars in Oncology in Collaboration with Pfizer
National Comprehensive Cancer Network issues Request for Proposals (RFP) for projects that develop and validate enduring approaches to improve the safe, effective, and efficient adoption of biosimilars in oncology.
MD Anderson and Sanofi announce strategic collaboration to accelerate oncology research and development
The University of Texas MD Anderson Cancer Center and Sanofi today announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune therapies, for patients with cancer.